Rabivax S Vaccine

The Rabivax S Vaccine contains active components called rabies antiserum. It belongs to the drug class as Immunoglobulin. It is also known as rabies immune globulin (Rabies antiserum) or rabies immune serum and is a medical treatment used to prevent the development of rabies in individuals who have been exposed to the rabies virus. One of the most significant advantages of the Rabivax S Vaccine is that it provides immediate passive immunity against the rabies virus. It is a crucial component of post-exposure prophylaxis (PEP) for individuals who have been bitten, scratched, or otherwise exposed to a potentially rabid animal. Neutralising the rabies virus at the exposure site can help prevent it from entering the nervous system and progressing to symptomatic rabies.

Post-exposure prophylaxis of rabies infection

Rabivax S Vaccine is typically administered through the intramuscular (IM) route. It is injected directly into the muscle, usually at or near the site of potential rabies exposure, to provide immediate passive immunity against the rabies virus. Always consult with a healthcare professional for proper administration guidance based on the specific circumstances of exposure.

Rabivax S Vaccine contains ‘Rabies Vaccine, Human’ that provides long-lasting protection against infection from the rabies virus. Rabivax S Vaccine helps develop immunity by forming antibodies that protect against infection caused by rabies viruses. It is essential to complete the vaccine course to prevent this fatal disease. It can be used in two ways: Pre-exposure prophylaxis (vaccinating before you come into contact with rabies virus at the age of 2-10 years) and post-exposure prophylaxis (vaccinating after you have come into contact with rabies virus). The rabies vaccine is used in all age groups

COLD CHAIN

1 VIAL